Skip to content

Sim 2 Pharma

Active Risk: not assessed
Limited partnershipfounded 2026active for less than a yearWilsonstraat 41, 2860 Sint-Katelijne-Waver, BelgiumKBO/BCE: BE 1035.947.033
Summary

Sim 2 Pharma is less than twelve months old. There is no public track record yet to compute a bankruptcy probability from. The company has been active since 2026 and the Belgian Official Gazette contains no insolvency or warning signals. No annual accounts have been filed with the National Bank.

Risk analysisFollow ReportCompare
Sim 2 PharmaActive
Risk analysis ReportCompare

Overview

Overview

Official details

Source: KBO
Status
Active since 24-03-2026 Normal situation
Activity
Other personal services NACE 96999and 1 other
Establishment unit
2.386.758.442 2860 Sint-Katelijne-Waver, since 24-03-2026
Peppol
Reachable since 21-04-2026
Company details

Board and ownership

Board
Board & ownership

Financial position

A small general or limited partnership need not file accounts
Signalsraises riskYoung companyShow the evidence

Signals

1 signal.
raises risk
raises risk · Young company
Founded in 2026, less than a year ago. Young companies fail more often than established ones; the risk is highest 2 to 8 years after founding.
KBO · incorporation date
Age against the risk zone
highest failure risk from 2 to 8 years under a year 0 10 years
Searched, nothing found (1)
neutral · No strike-offs in the KBO publications
That holds for every publication since incorporation in 2026.
KBO publications

Board & ownership

Directors

Directors
1 director, no change since 2026
GHIJSELINGS Simon
Statutory manager · appointed in the act of 26-03-2026 · term without a fixed end
Current
Office holders in the KBO →
See the board, name and registered office on a given date →
Signing authorityThe articles say who may bind the company, for example by signing a contract.
“De enige zaakvoerder vertegenwoordigt alleen de vennootschap jegens derden en in rechte, als eiser of verweerder. Indien er twee of meer…”
deed of 26-03-2026

Owners and capital

Shareholders

At incorporation act of 26-03-2026 ↗
  • GHIJSELINGS Simon gecommanditeerde of beherende vennoot · 1 share (50%) · €1 · volstort
  • GHIJSELINGS Ruffi commanditaire of stille vennoot · 1 share (50%) · €1 · volstort

Capital transactions

Capital over time
  1. 26-03-2026 Incorporation · €2 · 2 shares

Articles of association

Board and representation

Board powersThe board may in principle decide everything not reserved to the general meeting.
“Alle handelingen van intern bestuur, verrichtingen of besluiten waarvoor alleen de algemene vergadering bevoegd is”
Director compensationThe general meeting decides whether and how directors are paid for their mandate.
“Zaakvoerder, tenzij de algemene vergadering anders beslist”

Capital, shares and profit

Transfer restrictionThis rule says whether shareholders may sell their shares freely or need approval first.
“Dan met de schriftelijke instemming van alle andere vennoten, aandelen van een vennoot mogen, op straffe van nietigheid, niet worden…”

Audit, dissolution and liquidation

Dissolution ruleThe articles set when and by whom the company can be dissolved.
“Vrijwillige ontbinding, algemene vergadering met eenparigheid van aanwezige en geldig vertegenwoordigde stemmen”
Liquidation ruleIn a liquidation the creditors are paid first. What is left goes to the shareholders.
“Eenparigheid van aanwezige en geldig vertegenwoordigde stemmen, algemene vergadering”

Articles of association, deed of 26-03-2026 (in Dutch)

Network & group

Sim 2 Pharma shares no director with another company.

Connections & network

1 current director
Depth

The network starts from the directors of Sim 2 Pharma. Every other company they run is a node.

This company Company Director Shareholding +N: links not shown yet Click a node to look further, drag to arrange, zoom with the mouse wheel.

Timeline

Acts, filings and financial milestones

2026
26-03
Gazette deed Incorporation
Starting capital €2 · Appointment: GHIJSELINGS Simon (statutory manager) · Founder · Partner9 points ▸
  • Founder, GHIJSELINGS Simon
  • Founder, GHIJSELINGS Ruffi
  • Incorporation, 09-03-2026
  • Partner, GHIJSELINGS Simon (gecommanditeerde of beherende vennoot)
  • Partner, GHIJSELINGS Ruffi (commanditaire of stille vennoot)
  • Other provision, “sim2pha@gmail.com, contactgegevens” (deed in Dutch)
  • Director appointment, GHIJSELINGS Simon (statutory manager)
  • Other provision, “andere gegevens, onbeperkt” (deed in Dutch)
  • Founding capital, €2

Open the act in the Belgian Official Gazette

Gazette deed

Sources:Publications in the Belgian Official GazetteFilings with the National Bank

Company details

Register details

Identity

KBO record
Name Sim 2 Pharma in Dutch
Enterprise number 1035.947.033
Legal form Limited partnership
Status Active, normale toestand
Founded 24-03-2026
Entity type Legal entity
DurationMost companies exist for an unlimited period, until they are dissolved.
Unlimited
deed of 26-03-2026 (in Dutch)
Name clauseThe company operates under this name according to its articles.
Sim 2 Pharma
deed of 26-03-2026 (in Dutch)
Registered office clauseThe articles name the region of the registered office. The language of official documents depends on that region, among other things.
“Vlaams Gewest, 2860 Sint-Katelijne-Waver, Wilsonstraat 41”
deed of 26-03-2026 (in Dutch)

Registered office and establishments

Registered office Wilsonstraat 41, 2860 Sint-Katelijne-Waver, Belgium
Establishment unit Sim 2 Pha, Wilsonstraat 41, 2860 Sint-Katelijne-Waver since 24-03-2026 · unit number 2.386.758.442
E-mail Sim2Pha@gmail.com

Activities

NACEBEL 2025
96999 Other personal services main activity
47730 Retail sale of pharmaceutical products

Invoicing and payment

VAT number BE 1035.947.033
E-invoicing via Peppol
Reachable via Peppol
Peppol ID 0208:1035947033
Other Peppol ID 9925:BE1035947033
Registered 21-04-2026

Follow this company and you will hear the next morning if it leaves the Peppol register.

Register as of 4 November 2026 · Peppol Directory

Financial year and general meeting

Financial yearThe company draws up its annual accounts over this twelve-month period.
From 1 January to 31 December
deed of 26-03-2026 (in Dutch)
Annual meetingThe shareholders approve the annual accounts, among other things, at the annual meeting.
First Sunday of May at 12:00
deed of 26-03-2026 (in Dutch)
Meeting noticeShareholders are called at least fifteen days in advance. The articles set how.
“Per aangetekende brief of per e-mail indien gebruik werd gemaakt van de mogelijkheid vermeld in artikel 2:31 en 2:32 WVV, ten laatste…”
deed of 26-03-2026 (in Dutch)
Proxy ruleThe articles set whether a shareholder may be represented at the meeting by someone else.
“Niemand mag op de vergadering meer dan één vennoot vertegenwoordigen als gevolmachtigde, indien nodig en nuttig kan voor de aanvang van de…”
deed of 26-03-2026 (in Dutch)
Voting ruleThe articles set which majority the meeting decides by, for example a simple or a special majority.
“Gewone meerderheid, aanwezige en geldig vertegenwoordigde stemmen”
deed of 26-03-2026 (in Dutch)

Sites & property

Location
registered office establishment The establishment unit on the map

Buildings and parcels at the address

Ground area
1,314 m²
Building footprint
196 m²
Building volume
1,267 m³
Cadastral parcel Region Area Buildings Height / floors
12035A0525/00X000 Flanders 1,314 m² 1 · 196 m² 10.6 m · 2

We would like to set cookies. That happens only with your consent. What we measure